Application of Intraoperative Fluorescence-Guided Systems in Neurosurgery

The rapid evolution of neurosurgical techniques has positioned intraoperative fluorescence-guided systems as indispensable tools for enhancing surgical precision and ensuring patient safety. By leveraging specific tissue markers, these systems transform microscopic pathological changes—otherwise invisible to the naked eye—into macroscopic, visible fluorescent signals. This paradigm shift has moved neurosurgery from a reliance on "empirical resection" to a model of "visualized, precise excision." This article explores the core principles, primary modalities, and clinical application strategies of these advanced optical technologies.

Core Operating Principles and Fluorescence Mechanisms

At its essence, an intraoperative fluorescence-guided system exploits differences in photophysical properties. Under specific excitation light, target tissues emit fluorescence at distinct wavelengths, creating a stark contrast against surrounding normal brain tissue. The workflow typically involves three critical phases: labeling, excitation, and imaging.

First, prior to or during the procedure, surgeons apply solutions containing specific fluorescent probes to the target area. These probes exhibit high tissue targeting capabilities, selectively accumulating in tumor cells, abnormal vasculature, or inflamed tissues. Common markers include Indocyanine Green (ICG) and 5-Aminolevulinic Acid (5-ALA).

Second, when the surgical light or a dedicated light source emits excitation light of a specific wavelength (such as blue or green light), the labeled tissue absorbs photon energy, transitions to an excited state, and subsequently releases photons at lower energy levels. This process generates a visible fluorescent signal. Unlabeled normal brain tissue remains dark, resulting in high-contrast imagery.

Finally, highly sensitive fluorescence cameras capture these faint light signals in real-time, converting them into two-dimensional or three-dimensional fluorescent images for direct observation by the surgical team within the operative field.

Comparative Analysis of Leading Fluorescent Probes

Currently, the most mature fluorescent probes in clinical practice fall into two main categories: 5-Aminolevulinic Acid (5-ALA) and Indocyanine Green (ICG). They differ significantly in mechanism, applicability, and pros and cons.

5-ALA acts as a precursor drug that, upon entering the body, is enzymatically converted into Protoporphyrin IX (PpIX) within tumor cells. PpIX is a potent fluorescent substance.

Advantages: It offers exceptional specificity for malignant tumors like glioblastomas, clearly delineating tumor boundaries.
Limitations: It requires oral administration prior to surgery, leading to a delayed onset; it may cause side effects such as nausea; and its efficacy is suboptimal for certain low-grade gliomas.

In contrast, ICG is a dye administered intravenously, distributing primarily through the bloodstream.

Advantages: It acts rapidly, allowing for real-time assessment of tumor vascularity and metastases; it excels at marking leptomeningeal metastases and vascular lesions.
Limitations: Its specificity for non-vascular tumors is slightly lower than that of 5-ALA, and it carries a potential risk of immunogenicity.

Furthermore, emerging quantum dot fluorescent probes and immunofluorescent antibody labeling technologies are under development. These aim to further enhance sensitivity and targeting accuracy but have not yet achieved widespread clinical adoption.

Key Clinical Applications in Neurosurgery

The application of intraoperative fluorescence-guided systems has spanned multiple sub-specialties within neurosurgery. Their primary value lies in addressing the "gray areas" that are difficult to distinguish in traditional surgery.

In glioma resection, this system has become the gold standard. By utilizing 5-ALA labeling, surgeons can visually differentiate between tumor-normal tissue and areas of cancer cell infiltration, significantly reducing residual tumor (R1 resection) and improving postoperative survival rates.

For the management of leptomeningeal metastases, ICG demonstrates unique advantages. Since metastatic sites often reside on the meningeal surface with blurred boundaries against normal brain tissue, intravenous ICG injection rapidly highlights the lesions, assisting surgeons in precise biopsy or excision.

In the realm of functional neurosurgery, fluorescence technology also plays a pivotal role. For instance, during the localization of epileptic foci or exploration of motor function areas, marking abnormal metabolic regions or vascular malformations helps surgeons avoid critical functional zones, thereby reducing the risk of postoperative neurological deficits.

Clinical Implementation Protocols and Precautions

Despite technological maturity, strict adherence to standardized protocols is essential during actual clinical operations to ensure optimal outcomes.

Preoperative Assessment and Preparation: Verify that the patient has no history of iodine allergy (relevant for ICG). Calculate the timing for 5-ALA administration to ensure it is completed 24 hours before surgery.
Intraoperative Labeling: Select the appropriate probe based on the tumor type. For 5-ALA labeling, sufficient time must be allowed for PpIX accumulation; for ICG, intravenous bolus injection should occur during the procedure.
Excitation and Imaging: Activate the fluorescence channel of the surgical light and adjust the excitation wavelength to approximately 405–415 nm to avoid damaging the fluorescent signal with excessive light intensity. Utilize dedicated fluorescence microscopes or endoscopes to obtain high-definition images.
Postoperative Monitoring: Closely monitor the patient's vital signs after ICG injection to watch for rare but serious adverse reactions, such as anaphylactic shock.

In conclusion, intraoperative fluorescence-guided systems provide neurosurgeons with an "optical X-ray," dramatically enhancing the precision and safety of surgical interventions. As new probes are developed and equipment performance iterates, this technology is poised to play an even more central role in future neurosurgical diagnosis and treatment.